BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38322303)

  • 21. Regulatory mechanism of
    Wang A; Guo D; Cheng H; Jiang H; Liu X; Tie M
    PeerJ; 2022; 10():e14394. PubMed ID: 36415861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.
    Yue K; Yao X
    BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
    Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
    Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA 617 Targeting SERPINE1 Inhibited the Progression of Oral Squamous Cell Carcinoma.
    Zhao C; Liu Z
    Mol Cell Biol; 2021 May; 41(6):e0056520. PubMed ID: 33820852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
    Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
    Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0058063 contributes to oral squamous cell carcinoma development by sponging miR-145-5p and upregulating SERPINE1.
    Yu J; Lou Y; Hou M; Ma X; Wang L
    J Oral Pathol Med; 2022 Aug; 51(7):630-637. PubMed ID: 35778962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
    EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the Potential Molecular Mechanism of
    Tu Y; Wu Q; He J; Xu J; Yu S; Wang Q; Cheng Y; Yang Q; Xu S; Cao Y
    Front Pharmacol; 2021; 12():697704. PubMed ID: 34421596
    [No Abstract]   [Full Text] [Related]  

  • 31. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
    Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
    Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
    Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
    J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
    Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Sharif Siam MK; Sarker A; Sayeem MMS
    J Biomol Struct Dyn; 2021 Oct; 39(17):6467-6479. PubMed ID: 32746771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics analysis of dysregulated exosomal microRNAs derived from oral squamous cell carcinoma cells.
    Masaoka T; Shinozuka K; Ohara K; Tsuda H; Imai K; Tonogi M
    J Oral Sci; 2021 Mar; 63(2):174-178. PubMed ID: 33731508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
    Zhang C; Cai Q; Ke J
    Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
    Lin YC; Chen BS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.